Filing Details
- Accession Number:
- 0001209191-21-069781
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-15 17:06:24
- Reporting Period:
- 2021-12-13
- Accepted Time:
- 2021-12-15 17:06:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1741830 | Kronos Bio Inc. | KRON | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1826732 | Jorge Dimartino | C/O Kronos Bio, Inc. 1300 So. El Camino Real, Suite 300 San Mateo CA 94402 | Chief Medical Officer & Vp | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-12-13 | 16,152 | $12.36 | 117,785 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-13 | 250 | $12.82 | 117,535 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.